Saitama, Japan

Toshihiko Takemasa

This inventor holds 1 USPTO granted patent. Top assignee: Zeria Pharmaceutical Co., Ltd.. Active years: 1995.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihiko Takemasa. Retrieved from https://idiyas.com/inventor/toshihiko-takemasa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1995

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Toshihiko Takemasa

Introduction

Toshihiko Takemasa is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on digestive health.

Latest Patents

One of his key patents is for a trialkylamine derivative and ameliorant for digestive tract movement. This invention aims to improve digestive health and offers potential benefits for individuals suffering from gastrointestinal issues. He holds 1 patent in this area.

Career Highlights

Toshihiko Takemasa is currently employed at Zeria Pharmaceutical Co., Ltd. His work at this esteemed company has allowed him to focus on developing solutions that enhance digestive health and improve patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Yoshiaki Muto and Kyoji Chaki. Their combined expertise has contributed to the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Toshihiko Takemasa's contributions to the field of pharmaceuticals, particularly in digestive health, highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…